Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -6.97% is 76% below its 3-year average of -3.96%, near the low end of its 3-year range (-7.15%–0.00%).
6.41% below its 12-month average of -6.55%.
Reported quarterly return on assets; no daily interpolation. Q1 FY2026 (2026-07-31): 0.00%.
RETURN ON ASSETS (ROA)
-6.97%
RETURN ON ASSETS (ROA) AVG TTM
-6.55%
RETURN ON ASSETS (ROA) AVG 3Y
-3.96%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-6.41%
CURRENT VS 3Y AVG
-76.01%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.18%
median of 668 covered companies
CURRENT VS SECTOR MEDIAN
+76.91%
vs the sector median at left
MiniMed Group, Inc. Common Stock
Market Cap
$5.54B
Return on Assets (ROA)
-6.97%
TTM Avg
-6.55%
3Y Avg
-3.96%
5Y Avg
N/A
Market Cap
$5.37B
Return on Assets (ROA)
15.41%
TTM Avg
17.55%
3Y Avg
14.67%
5Y Avg
15.71%
Market Cap
$5.78B
Return on Assets (ROA)
9.00%
TTM Avg
0.15%
3Y Avg
10.71%
5Y Avg
-11.86%
Market Cap
$5.29B
Return on Assets (ROA)
-17.02%
TTM Avg
-21.01%
3Y Avg
-19.47%
5Y Avg
-13.88%
Market Cap
$5.28B
Return on Assets (ROA)
-45.20%
TTM Avg
-56.55%
3Y Avg
-55.28%
5Y Avg
-47.01%
Market Cap
$5.23B
Return on Assets (ROA)
-78.04%
TTM Avg
-72.67%
3Y Avg
-59.05%
5Y Avg
-50.29%
Market Cap
$5.86B
Return on Assets (ROA)
-20.67%
TTM Avg
-16.00%
3Y Avg
-20.09%
5Y Avg
-20.45%
Market Cap
$5.15B
Return on Assets (ROA)
-66.02%
TTM Avg
-31.80%
3Y Avg
-35.60%
5Y Avg
-41.38%
Market Cap
$5.95B
Return on Assets (ROA)
-31.62%
TTM Avg
-41.85%
3Y Avg
-50.05%
5Y Avg
-46.34%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $5.54B | -6.97% | -6.55% | -3.96% | N/A |
| Doximity, Inc. (DOCS)vs › | $5.37B | 15.41% | 17.55% | 14.67% | 15.71% |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.78B | 9.00% | 0.15% | 10.71% | -11.86% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.29B | -17.02% | -21.01% | -19.47% | -13.88% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.28B | -45.20% | -56.55% | -55.28% | -47.01% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.23B | -78.04% | -72.67% | -59.05% | -50.29% |
| CG Oncology Inc. (CGON)vs › | $5.86B | -20.67% | -16.00% | -20.09% | -20.45% |
| Erasca, Inc. (ERAS)vs › | $5.15B | -66.02% | -31.80% | -35.60% | -41.38% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.95B | -31.62% | -41.85% | -50.05% | -46.34% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.08B | 5.08% | 4.88% | 4.58% | 3.44% |
ROA
-7.0%
ROE
-9.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-04-24 | -7.15% |
| 2025-04-30 | -5.95% |
| 2024-04-30 | -2.74% |
| 2023-04-30 | 0.00% |
